Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Int J Mol Sci ; 18(12)2017 11 24.
Article in English | MEDLINE | ID: mdl-29186806

ABSTRACT

Maize (Zea mays L.) is a staple food in many parts of Africa, but the endosperm generally contains low levels of the pro-vitamin A carotenoid ß-carotene, leading to vitamin A deficiency disease in populations relying on cereal-based diets. However, maize endosperm does accumulate high levels of other carotenoids, including zeaxanthin, which is derived from ß-carotene via two hydroxylation reactions. Blocking these reactions could therefore improve the endosperm ß-carotene content. Accordingly, we used RNA interference (RNAi) to silence the endogenous ZmBCH1 and ZmBCH2 genes, which encode two non-heme di-iron carotenoid ß-hydroxylases. The genes were silenced in a range of maize genetic backgrounds by introgressing the RNAi cassette, allowing us to determine the impact of ZmBCH1/ZmBCH2 silencing in diverse hybrids. The ß-carotene content of the endosperm increased substantially in all hybrids in which ZmBCH2 was silenced, regardless of whether or not ZmBCH1 was silenced simultaneously. However, the ß-carotene content did not change significantly in C17 hybrids (M7 × C17 and M13 × C17) compared to C17 alone, because ZmBCH2 is already expressed at negligible levels in the C17 parent. Our data indicate that ZmBCH2 is primarily responsible for the conversion of ß-carotene to zeaxanthin in maize endosperm.


Subject(s)
Endosperm/metabolism , Mixed Function Oxygenases/genetics , Plant Proteins/genetics , RNA Interference , Zea mays/genetics , beta Carotene/metabolism , Genotype , Mixed Function Oxygenases/metabolism , Plant Proteins/metabolism , Zea mays/metabolism , Zeaxanthins/metabolism
2.
Plant Cell Rep ; 36(6): 933-945, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28314904

ABSTRACT

KEY MESSAGE: The AtOR gene enhances carotenoid levels in corn by promoting the formation of plastoglobuli when the carotenoid pool is limited, but has no further effect when carotenoids are already abundant. The cauliflower orange (or) gene mutation influences carotenoid accumulation in plants by promoting the transition of proplastids into chromoplasts, thus creating intracellular storage compartments that act as metabolic sink. We overexpressed the Arabidopsis OR gene under the control of the endosperm-specific wheat LMW glutenin promoter in a white corn variety that normally accumulates only trace amounts of carotenoids. The total endosperm carotenoid content in the best-performing AtOR transgenic corn line was 32-fold higher than wild-type controls (~25 µg/g DW at 30 days after pollination) but the principal carotenoids remained the same, suggesting that AtOR increases the abundance of existing carotenoids without changing the metabolic composition. We analyzed the expression of endogenous genes representing the carotenoid biosynthesis and MEP pathways, as well as the plastid fusion/translocation factor required for chromoplast formation, but only the DXS1 gene was upregulated in the transgenic corn plants. The line expressing AtOR at the highest level was crossed with four transgenic corn lines expressing different carotenogenic genes and accumulating different carotenoids. The introgression of AtOR increased the carotenoid content of the hybrids when there was a limited carotenoid pool in the parental line, but had no effect when carotenoids were already abundant in the parent. The AtOR gene therefore appears to enhance carotenoid levels by promoting the formation of carotenoid-sequestering plastoglobuli when the carotenoid pool is limited, but has no further effect when carotenoids are already abundant because high levels of carotenoids can induce the formation of carotenoid-sequestering plastoglobuli even in the absence of AtOR.


Subject(s)
Arabidopsis/metabolism , Carotenoids/metabolism , Plant Proteins/metabolism , Plants, Genetically Modified/metabolism , Zea mays/metabolism , Arabidopsis/genetics , Gene Expression Regulation, Plant , Plant Proteins/genetics , Plants, Genetically Modified/genetics , Zea mays/genetics
3.
Transgenic Res ; 26(1): 13-23, 2017 02.
Article in English | MEDLINE | ID: mdl-27567632

ABSTRACT

Astaxanthin is a high-value ketocarotenoid rarely found in plants. It is derived from ß-carotene by the 3-hydroxylation and 4-ketolation of both ionone end groups, in reactions catalyzed by ß-carotene hydroxylase and ß-carotene ketolase, respectively. We investigated the feasibility of introducing an extended carotenoid biosynthesis pathway into rice endosperm to achieve the production of astaxanthin. This allowed us to identify potential metabolic bottlenecks that have thus far prevented the accumulation of this valuable compound in storage tissues such as cereal grains. Rice endosperm does not usually accumulate carotenoids because phytoene synthase, the enzyme responsible for the first committed step in the pathway, is not present in this tissue. We therefore expressed maize phytoene synthase 1 (ZmPSY1), Pantoea ananatis phytoene desaturase (PaCRTI) and a synthetic Chlamydomonas reinhardtii ß-carotene ketolase (sCrBKT) in transgenic rice plants under the control of endosperm-specific promoters. The resulting grains predominantly accumulated the diketocarotenoids canthaxanthin, adonirubin and astaxanthin as well as low levels of monoketocarotenoids. The predominance of canthaxanthin and adonirubin indicated the presence of a hydroxylation bottleneck in the ketocarotenoid pathway. This final rate-limiting step must therefore be overcome to maximize the accumulation of astaxanthin, the end product of the pathway.


Subject(s)
Geranylgeranyl-Diphosphate Geranylgeranyltransferase/genetics , Oxidoreductases/genetics , Oxygenases/genetics , Chlamydomonas reinhardtii/enzymology , Endosperm/genetics , Endosperm/metabolism , Genetic Engineering , Metabolic Engineering/methods , Metabolic Networks and Pathways/genetics , Mixed Function Oxygenases/genetics , Oryza/genetics , Oryza/growth & development , Oxygenases/metabolism , Plants, Genetically Modified/genetics , Plants, Genetically Modified/metabolism , Xanthophylls/biosynthesis , Xanthophylls/genetics , Zea mays/enzymology , beta Carotene/biosynthesis , beta Carotene/genetics
4.
PLoS One ; 11(9): e0162410, 2016.
Article in English | MEDLINE | ID: mdl-27589396

ABSTRACT

Flower color is an important characteristic that determines the commercial value of ornamental plants. Gentian flowers occur in a limited range of colors because this species is not widely cultivated as a cut flower. Gentiana lutea L. var. aurantiaca (abbr, aurantiaca) is characterized by its orange flowers, but the specific pigments responsible for this coloration are unknown. We therefore investigated the carotenoid and flavonoid composition of petals during flower development in the orange-flowered gentian variety of aurantiaca and the yellow-flowered variety of G. lutea L. var. lutea (abbr, lutea). We observed minor varietal differences in the concentration of carotenoids at the early and final stages, but only aurantiaca petals accumulated pelargonidin glycosides, whereas these compounds were not found in lutea petals. We cloned and sequenced the anthocyanin biosynthetic gene fragments from petals, and analyzed the expression of these genes in the petals of both varieties to determine the molecular mechanisms responsible for the differences in petal color. Comparisons of deduced amino acid sequences encoded by the isolated anthocyanin cDNA fragments indicated that chalcone synthase (CHS), chalcone isomerase (CHI), anthocyanidin synthase 1 (ANS1) and ANS2 are identical in both aurantiaca and lutea varieties whereas minor amino acid differences of the deduced flavonone 3-hydroxylase (F3H) and dihydroflavonol 4-reductase (DFR) between both varieties were observed. The aurantiaca petals expressed substantially higher levels of transcripts representing CHS, F3H, DFR, ANS and UDP-glucose:flavonoid-3-O-glucosyltransferase genes, compared to lutea petals. Pelargonidin glycoside synthesis in aurantiaca petals therefore appears to reflect the higher steady-state levels of pelargonidin synthesis transcripts. Moreover, possible changes in the substrate specificity of DFR enzymes may represent additional mechanisms for producing red pelargonidin glycosides in petals of aurantiaca. Our report describing the exclusive accumulation of pelargonidin glycosides in aurantiaca petals may facilitate the modification of gentian flower color by the production of red anthocyanins.


Subject(s)
Anthocyanins/analysis , Carotenoids/analysis , Color , Flowers/chemistry , Gene Expression Regulation, Plant , Gentiana/chemistry , Amino Acid Sequence , Gentiana/genetics , Pigmentation/genetics , Plant Proteins/genetics
5.
Plant J ; 87(5): 455-71, 2016 09.
Article in English | MEDLINE | ID: mdl-27155093

ABSTRACT

Plant synthetic biology is still in its infancy. However, synthetic biology approaches have been used to manipulate and improve the nutritional and health value of staple food crops such as rice, potato and maize. With current technologies, production yields of the synthetic nutrients are a result of trial and error, and systematic rational strategies to optimize those yields are still lacking. Here, we present a workflow that combines gene expression and quantitative metabolomics with mathematical modeling to identify strategies for increasing production yields of nutritionally important carotenoids in the seed endosperm synthesized through alternative biosynthetic pathways in synthetic lines of white maize, which is normally devoid of carotenoids. Quantitative metabolomics and gene expression data are used to create and fit parameters of mathematical models that are specific to four independent maize lines. Sensitivity analysis and simulation of each model is used to predict which gene activities should be further engineered in order to increase production yields for carotenoid accumulation in each line. Some of these predictions (e.g. increasing Zmlycb/Gllycb will increase accumulated ß-carotenes) are valid across the four maize lines and consistent with experimental observations in other systems. Other predictions are line specific. The workflow is adaptable to any other biological system for which appropriate quantitative information is available. Furthermore, we validate some of the predictions using experimental data from additional synthetic maize lines for which no models were developed.


Subject(s)
Carotenoids/metabolism , Models, Theoretical , Zea mays/metabolism , Computational Biology/methods , Metabolomics/methods
6.
Plant Biotechnol J ; 14(1): 195-205, 2016 Jan.
Article in English | MEDLINE | ID: mdl-25857664

ABSTRACT

The profile of secondary metabolites in plants reflects the balance of biosynthesis, degradation and storage, including the availability of precursors and products that affect the metabolic equilibrium. We investigated the impact of the precursor-product balance on the carotenoid pathway in the endosperm of intact rice plants because this tissue does not normally accumulate carotenoids, allowing us to control each component of the pathway. We generated transgenic plants expressing the maize phytoene synthase gene (ZmPSY1) and the bacterial phytoene desaturase gene (PaCRTI), which are sufficient to produce ß-carotene in the presence of endogenous lycopene ß-cyclase. We combined this mini-pathway with the Arabidopsis thaliana genes AtDXS (encoding 1-deoxy-D-xylulose 5-phosphate synthase, which supplies metabolic precursors) or AtOR (the ORANGE gene, which promotes the formation of a metabolic sink). Analysis of the resulting transgenic plants suggested that the supply of isoprenoid precursors from the MEP pathway is one of the key factors limiting carotenoid accumulation in the endosperm and that the overexpression of AtOR increased the accumulation of carotenoids in part by up-regulating a series of endogenous carotenogenic genes. The identification of metabolic bottlenecks in the pathway will help to refine strategies for the creation of engineered plants with specific carotenoid profiles.


Subject(s)
Biosynthetic Pathways , Carotenoids/biosynthesis , Endosperm/metabolism , Oryza/metabolism , Arabidopsis/genetics , Biosynthetic Pathways/genetics , Endosperm/genetics , Endosperm/ultrastructure , Gene Expression Regulation, Plant , Genes, Plant , Genotype , Oryza/genetics , Phenotype , Plants, Genetically Modified , Up-Regulation/genetics
7.
New Phytol ; 209(2): 650-63, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26377696

ABSTRACT

The apocarotenoid crocetin and its glycosylated derivatives, crocins, confer the red colour to saffron. Crocetin biosynthesis in saffron is catalysed by the carotenoid cleavage dioxygenase CCD2 (AIG94929). No homologues have been identified in other plant species due to the very limited presence of crocetin and its derivatives in the plant kingdom. Spring Crocus species with yellow flowers accumulate crocins in the stigma and tepals. Four carotenoid CCDs, namely CaCCD1, CaCCD2 and CaCCD4a/b and CaCCD4c were first cloned and characterized. CaCCD2 was localized in plastids, and a longer CCD2 version, CsCCD2L, was also localized in this compartment. The activity of CaCCD2 was assessed in Escherichia coli and in a stable rice gene function characterization system, demonstrating the production of crocetin in both systems. The expression of all isolated CCDs was evaluated in stigma and tepals at three key developmental stages in relation with apocarotenoid accumulation. CaCCD2 expression parallels crocin accumulation, but C14 apocarotenoids most likely are associated to the CaCCD1 activity in Crocus ancyrensis flowers. The specific CCD2 localization and its membrane interaction will contribute to the development of a better understanding of the mechanism of crocetin biosynthesis and regulation in the chromoplast.


Subject(s)
Carotenoids/biosynthesis , Crocus/metabolism , Dioxygenases/metabolism , Plant Proteins/metabolism , Plastids/enzymology , Carotenoids/metabolism , Cell Line, Transformed , Cloning, Molecular , Crocus/genetics , Dioxygenases/chemistry , Dioxygenases/genetics , Escherichia coli/genetics , Flowers/enzymology , Flowers/genetics , Gene Expression Regulation, Plant , Oryza/cytology , Oryza/genetics , Phylogeny , Plant Proteins/genetics , Plants, Genetically Modified , Plastids/genetics , Sequence Homology, Amino Acid , Nicotiana/genetics , Vitamin A/analogs & derivatives , Zeaxanthins/metabolism
8.
PLoS One ; 10(6): e0128758, 2015.
Article in English | MEDLINE | ID: mdl-26030746

ABSTRACT

The assignment of functions to genes in the carotenoid biosynthesis pathway is necessary to understand how the pathway is regulated and to obtain the basic information required for metabolic engineering. Few carotenoid ε-hydroxylases have been functionally characterized in plants although this would provide insight into the hydroxylation steps in the pathway. We therefore isolated mRNA from the endosperm of maize (Zea mays L., inbred line B73) and cloned a full-length cDNA encoding CYP97C19, a putative heme-containing carotenoid ε hydroxylase and member of the cytochrome P450 family. The corresponding CYP97C19 genomic locus on chromosome 1 was found to comprise a single-copy gene with nine introns. We expressed CYP97C19 cDNA under the control of the constitutive CaMV 35S promoter in the Arabidopsis thaliana lut1 knockout mutant, which lacks a functional CYP97C1 (LUT1) gene. The analysis of carotenoid levels and composition showed that lutein accumulated to high levels in the rosette leaves of the transgenic lines but not in the untransformed lut1 mutants. These results allowed the unambiguous functional annotation of maize CYP97C19 as an enzyme with strong zeinoxanthin ε-ring hydroxylation activity.


Subject(s)
Carotenoids/genetics , Carotenoids/metabolism , Mixed Function Oxygenases/genetics , Mixed Function Oxygenases/metabolism , Zea mays/genetics , Zea mays/metabolism , Amino Acid Sequence , Arabidopsis/genetics , Arabidopsis/metabolism , Arabidopsis Proteins/genetics , Arabidopsis Proteins/metabolism , Cloning, Molecular/methods , Cytochrome P-450 Enzyme System/genetics , Cytochrome P-450 Enzyme System/metabolism , DNA, Complementary/genetics , Endosperm/genetics , Endosperm/metabolism , Gene Expression Regulation, Plant/genetics , Genes, Plant/genetics , Lutein/genetics , Lutein/metabolism , Plant Leaves/genetics , Plant Leaves/metabolism , Promoter Regions, Genetic/genetics , RNA, Messenger/genetics , Sequence Alignment
9.
Int J Dev Biol ; 57(6-8): 565-76, 2013.
Article in English | MEDLINE | ID: mdl-24166439

ABSTRACT

Metabolic engineering in plants can be used to increase the abundance of specific valuable metabolites, but single-point interventions generally do not improve the yields of target metabolites unless that product is immediately downstream of the intervention point and there is a plentiful supply of precursors. In many cases, an intervention is necessary at an early bottleneck, sometimes the first committed step in the pathway, but is often only successful in shifting the bottleneck downstream, sometimes also causing the accumulation of an undesirable metabolic intermediate. Occasionally it has been possible to induce multiple genes in a pathway by controlling the expression of a key regulator, such as a transcription factor, but this strategy is only possible if such master regulators exist and can be identified. A more robust approach is the simultaneous expression of multiple genes in the pathway, preferably representing every critical enzymatic step, therefore removing all bottlenecks and ensuring completely unrestricted metabolic flux. This approach requires the transfer of multiple enzyme-encoding genes to the recipient plant, which is achieved most efficiently if all genes are transferred at the same time. Here we review the state of the art in multigene transformation as applied to metabolic engineering in plants, highlighting some of the most significant recent advances in the field.


Subject(s)
Metabolic Engineering/methods , Metabolic Networks and Pathways , Plants, Genetically Modified , Plants/genetics , Biotechnology , DNA, Bacterial/genetics , DNA, Plant/genetics , Enzymes/metabolism , Fatty Acids, Unsaturated/metabolism , Gene Silencing , Gene Transfer Techniques , Genetic Engineering/methods , Open Reading Frames , Plants, Genetically Modified/genetics , Plants, Genetically Modified/metabolism , Synthetic Biology/methods , Transcription Factors/metabolism , Transgenes
10.
Nutr Res Rev ; 26(2): 235-45, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24134863

ABSTRACT

The biofortification of staple crops with vitamins is an attractive strategy to increase the nutritional quality of human food, particularly in areas where the population subsists on a cereal-based diet. Unlike other approaches, biofortification is sustainable and does not require anything more than a standard food-distribution infrastructure. The health-promoting effects of vitamins depend on overall intake and bioavailability, the latter influenced by food processing, absorption efficiency and the utilisation or retention of the vitamin in the body. The bioavailability of vitamins in nutritionally enriched foods should ideally be adjusted to achieve the dietary reference intake in a reasonable portion. Current vitamin biofortification programmes focus on the fat-soluble vitamins A and E, and the water-soluble vitamins C and B9 (folate), but the control of dosage and bioavailability has been largely overlooked. In the present review, we discuss the vitamin content of nutritionally enhanced foods developed by conventional breeding and genetic engineering, focusing on dosage and bioavailability. Although the biofortification of staple crops could potentially address micronutrient deficiency on a global scale, further research is required to develop effective strategies that match the bioavailability of vitamins to the requirements of the human diet.


Subject(s)
Avitaminosis/diet therapy , Crops, Agricultural , Diet , Food, Fortified , Nutritive Value , Vitamins/administration & dosage , Biological Availability , Humans
11.
Plant Mol Biol ; 83(1-2): 5-19, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23430566

ABSTRACT

Genetically engineered (GE) crops can be used as part of a combined strategy to address food insecurity, which is defined as a lack of sustainable access to safe and nutritious food. In this article, we discuss the causes and consequences of food insecurity in the developing world, and the indirect economic impact on industrialized countries. We dissect the healthcare costs and lost productivity caused by food insecurity, and evaluate the relative merits of different intervention programs including supplementation, fortification and the deployment of GE crops with higher yields and enhanced nutritional properties. We provide clear evidence for the numerous potential benefits of GE crops, particularly for small-scale and subsistence farmers. GE crops with enhanced yields and nutritional properties constitute a vital component of any comprehensive strategy to tackle poverty, hunger and malnutrition in developing countries and thus reduce the global negative economic effects of food insecurity.


Subject(s)
Food Supply/economics , Food, Genetically Modified/economics , Genetic Engineering/methods , Crops, Agricultural/economics , Crops, Agricultural/genetics , Deficiency Diseases/economics , Delivery of Health Care/economics , Delivery of Health Care/organization & administration , Developing Countries , Dietary Supplements/economics , Oryza/economics , Oryza/genetics , Poverty/prevention & control , Zea mays/economics , Zea mays/genetics
12.
Plant Biotechnol J ; 11(2): 129-41, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22970850

ABSTRACT

Antioxidants are protective molecules that neutralize reactive oxygen species and prevent oxidative damage to cellular components such as membranes, proteins and nucleic acids, therefore reducing the rate of cell death and hence the effects of ageing and ageing-related diseases. The fortification of food with antioxidants represents an overlap between two diverse environments, namely fortification of staple foods with essential nutrients that happen to have antioxidant properties (e.g. vitamins C and E) and the fortification of luxury foods with health-promoting but non-essential antioxidants such as flavonoids as part of the nutraceuticals/functional foods industry. Although processed foods can be artificially fortified with vitamins, minerals and nutraceuticals, a more sustainable approach is to introduce the traits for such health-promoting compounds at source, an approach known as biofortification. Regardless of the target compound, the same challenges arise when considering the biofortification of plants with antioxidants, that is the need to modulate endogenous metabolic pathways to increase the production of specific antioxidants without affecting plant growth and development and without collateral effects on other metabolic pathways. These challenges become even more intricate as we move from the engineering of individual pathways to several pathways simultaneously. In this review, we consider the state of the art in antioxidant biofortification and discuss the challenges that remain to be overcome in the development of nutritionally complete and health-promoting functional foods.


Subject(s)
Antioxidants/metabolism , Crops, Agricultural/chemistry , Food, Fortified , Genetic Engineering , Ascorbic Acid/biosynthesis , Carotenoids/biosynthesis , Crops, Agricultural/genetics , Flavonoids/biosynthesis , Food, Organic , Functional Food , Melatonin/biosynthesis , Nutritive Value , Plants, Genetically Modified/chemistry , Plants, Genetically Modified/genetics , Ubiquinone/analogs & derivatives , Ubiquinone/biosynthesis
13.
Genes Nutr ; 8(1): 29-41, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22926437

ABSTRACT

Malnutrition is a prevalent and entrenched global socioeconomic challenge that reflects the combined impact of poverty, poor access to food, inefficient food distribution infrastructure, and an over-reliance on subsistence mono-agriculture. The dependence on staple cereals lacking many essential nutrients means that malnutrition is endemic in developing countries. Most individuals lack diverse diets and are therefore exposed to nutrient deficiencies. Plant biotechnology could play a major role in combating malnutrition through the engineering of nutritionally enhanced crops. In this article, we discuss different approaches that can enhance the nutritional content of staple crops by genetic engineering (GE) as well as the functionality and safety assessments required before nutritionally enhanced GE crops can be deployed in the field. We also consider major constraints that hinder the adoption of GE technology at different levels and suggest policies that could be adopted to accelerate the deployment of nutritionally enhanced GE crops within a multicomponent strategy to combat malnutrition.

SELECTION OF CITATIONS
SEARCH DETAIL
...